Development of a PHBV nanoparticle as a peptide vehicle for NOD1 activation

5Citations
Citations of this article
13Readers
Mendeley users who have this article in their library.

Abstract

NOD1 is an intracellular receptor that, when activated, induces gene expression of pro-inflammatory factors promoting macrophages and neutrophils recruitment at the infection site. However, iE-DAP, the dipeptide agonist that promotes this receptor's activation, cannot permeate cell membranes. To develop a nanocarrier capable of achieving a high and prolonged activation over time, iE-DAP was encapsulated in nanoparticles (NPs) made of poly (3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV). The physicochemical properties, colloidal stability, encapsulation efficiency, and cellular uptake of iE-DAP-loaded PHVB NPs were analyzed. Results evidenced that physicochemical properties of iE-DAP-loaded NPs remained stable over time, and NPs were efficiently internalized into cells, a process that depends on time and concentration. Moreover, our results showed that NPs elicited a controlled cargo release in vitro, and the encapsulated agonist response was higher than its free form, suggesting the possibility of activating intracellular receptors triggering an immune response through the release of NOD1 agonist.

Cite

CITATION STYLE

APA

Cabaña-Brunod, M., Herrera, P. A., Márquez-Miranda, V., Llancalahuen, F. M., Duarte, Y., González-Nilo, D., … Otero, C. (2021). Development of a PHBV nanoparticle as a peptide vehicle for NOD1 activation. Drug Delivery, 28(1), 1020–1030. https://doi.org/10.1080/10717544.2021.1923862

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free